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Abstract
In Liaoning Province in northeastern China, we found a G6PD-deficient patient at the age of
3. By the classification of the World Health Organization, this patient was categorized as class I
(very severe G6PD deficiency). When we investigated the G6PD gene of the patient, we found
that he had a replacement of G to A at nucleotide 1339. As a result, the amino acid at position 447
should change from Gly to Arg. This replacement is known as G6PD Santiago de Cuba, because it
was first discovered in a Cuban boy who showed heavy chronic anemia. Today, 28 G6PD variants
have been reported in the Chinese population, and all are categorized as class II (severe deficiency)
or class III (mild deficiency);in class II or III deficiency, anemia is not present in daily life, but
hemolytic attack can occur when the carrier ingests certain oxidative medicines or foods. This
is the first report of a G6PD-deficient Chinese patient in the category of class I. We intended to
find other G6PD-deficient cases in northeastern China and tested several hundred blood samples,
but no cases of G6PD deficiency were found (0/414). In central China, where falciparum malaria
was endemic from the 1950s to 1970s, we found two G6PD-deficient cases (2/27) and the other
members from their families whose variant type was G6PD Kaiping (1388GT), which is a common
variant in the Chinese population.
KEYWORDS: hemolytic anemia, Chinese, glucose-6-phosphate dehydrogenase, G6PD Santiago
de Cuba, malaria
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In Liaoning Province in northeastern China,  we found a G6PD-deﬁcient patient at the age of 3.  By the 
classiﬁcation of the World Health Organization,  this patient was categorized as class I (very severe 
G6PD deﬁciency).  When we investigated the G6PD gene of the patient,  we found that he had a 
replacement of G to A at nucleotide 1339.  As a result,  the amino acid at position 447 should change 
from Gly to Arg.  This replacement is known as G6PD Santiago de Cuba,  because it was ﬁrst discov-
ered in a Cuban boy who showed heavy chronic anemia.  Today,  28 G6PD variants have been reported 
in the Chinese population,  and all are categorized as class II (severe deﬁciency) or class III (mild 
deﬁciency); in class II or III deﬁciency,  anemia is not present in daily life,  but hemolytic attack can 
occur when the carrier ingests certain oxidative medicines or foods.  This is the ﬁrst report of a 
G6PD-deﬁcient Chinese patient in the category of class I.  We intended to ﬁnd other G6PD-deﬁcient 
cases in northeastern China and tested several hundred blood samples,  but no cases of G6PD deﬁ-
ciency were found (0/414).  In central China,  where falciparum malaria was endemic from the 1950s to 
1970s,  we found two G6PD-deﬁcient cases (2/27) and the other members from their families whose 
variant type was G6PD Kaiping (1388G＞T),  which is a common variant in the Chinese population.
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malaria
lucose-6-phosphate dehydrogenase (G6PD) deﬁ-
ciency is one of the most frequent hereditary 
abnormalities.  The gene G6PD is distributed in 13 
exons on the X-chromosome,  and the length of the 
open reading frame is 1545 bases [1].  Almost all 
cases of G6PD deﬁciency are caused by one amino-
acid change due to a point mutation of the genomic 
DNA,  and about 140 molecular abnormalities of the 
G6PD genotype have been identiﬁed [2].  As an 
enzyme,  the monomer of G6PD consists of 515 amino 
acids; 2 monomers form a homo-dimer attaching at the 
site of the dimer interface.  Once the amino acid sub-
G
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stitution occurs near the dimer interface,  G6PD 
activity becomes very low.  The dimer formation may 
be important for the function of the active enzyme 
[3].  The World Health Organization (WHO) catego-
rizes G6PD-deﬁciency variants into 3 classes accord-
ing to their severity.  The class I variant shows very 
low G6PD activity (less than 1ｵ of that in a normal 
individual),  and carriers of these genes suﬀer from 
heavy anemia because hemolysis occurs chronically.  
The class II variant shows low G6PD activity (less 
than 10ｵ of residual enzyme activity) and does not 
pose as serious a problem in daily life.  Hemolytic 
attack occurs only when the carrier ingests certain 
foods or medicines.  The class III variant shows 
10-60ｵ of residual enzyme activity and hemolysis 
occurs only in rare cases [4].  Females,  but not 
males,  can be heterozygous for the class I or class II 
G6PD variants,  and such carriers are sometimes 
categorized into class III,  because half of their red 
blood cells lack the G6PD enzyme activity,  while the 
other half have full activity.
　 We have proviously investigated variants of G6PD 
deﬁciency in Asian countries [5-12],  where this 
abnormality is highly prevalent in malaria-endemic 
areas.  We have introduced a rapid diagnosis method 
for malaria [13] and rapid G6PD-deﬁciency tests 
[14-16] in malaria-endemic areas.  Using these meth-
ods,  patients are notiﬁed of the results of blood 
examination within 30 min and are able to receive 
anti-malarial medicine including primaquine [17,  18].  
Primaquine can kill gametocytes,  the sexual stage of 
malaria parasites,  which are the cause of malaria 
transmission to mosquitoes.  However,  when G6PD-
deﬁcient persons take primaquine,  a hemolytic attack 
can occur.  Without G6PD,  erythrocytes cannot pre-
pare a suﬃcient amount of reduced pyridine nucleotide 
and reduced glutathione,  and cannot prevent oxidant 
attack by primaquine.  Thus,  primaquine should not be 
administered to malaria patients before conﬁrming 
their G6PD activity.  In our previous studies,  we have 
diagnosed more than 200 G6PD-deﬁciency cases and 
found 15 variants of G6PD deﬁciency in Southeast 
Asian countries.  These G6PD variants were all cat-
egorized as class II.  Among them,  we discovered 
three new G6PD variants,  which we designated G6PD 
Surabaya [5],  G6PD Bajo Maumere [10],  and 
G6PD Bao Loc [11].
　 Numerous studies have investigated G6PD deﬁ-
ciency in the Chinese population.  Twenty-two molecu-
lar variants were reported from the southern part of 
China,  which includes many malaria-endemic areas 
[19-22].  Some other variants were reported from 
Chinese populations in Taiwan [23-26],  Singapore 
[27],  Malaysia [12,  28],  Indonesia [5] and Hawaii 
[29].  These G6PD variants were all categorized as 
class II or class III.  In this report we present the ﬁrst 
Chinese case of G6PD deﬁciency categorized as class 
I.  We also conducted a G6PD test in northeastern and 
central China to investigate the G6PD variants pres-
ent in these areas.
Materials and Methods
　 This study was approved by the Ethical Com-
mittees of China Medical University,  Jichi Medical 
University,  Shenyang Infectious Disease Hospital,  
and Hubei Center for Disease Control and Preven-
tion.
　 A case report. A 3-year-old boy who showed 
heavy anemia was admitted to Shengjing Hospital of 
China Medical University,  Shenyang.  His erythrocyte 
number was 1.25×1012/L,  his hemoglobin concentra-
tion was 45g/L,  and his total bilirubin level was 
24.3µmol/L.  He had had infant jaundice since birth,  
and this condition was still present upon admission.  
He was ﬁrst diagnosed with hemolytic anemia,  and 
then with G6PD deﬁciency,  because his G6PD activ-
ity was found to be less than 1ｵ of the normal level.  
By the classiﬁcation of the World Health Organiza-
tion [4],  he was categorized as class I.  Artiﬁcial 
nutrition and recuperation led to a recovery of his 
scores (RBC: 2.98×1012/L; Hb: 93g/L),  and he 
was discharged.  We asked his family members for 
permission to analyze their G6PD activity and se-
quence their G6PD gene,  and received informed con-
sent (Fig.  1A).
　 Participants in the G6PD test. We asked 
outpatients of Shenyang Infectious Disease Hospital,  
Shenyang,  if they would agree to be tested for G6PD 
activity upon providing a venous blood sample for 
other purposes,  e.g.,  for an RBC count,  a WBC 
count,  or blood sugar levels.  From patients who 
provided informed consent,  we collected about 10µl of 
blood onto a ﬁlter sheet,  which was then dried and 
stored at －20℃.  There were 414 males and 105 
females who agreed to be tested for G6PD activity.  In 
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addition,  we visited a junior high school in Suizhou,  
which is in Hubei Province in central China,  and 
received informed consent from the principle and stu-
dents to test G6PD activity.  Fifty students (27 males 
and 23 females) participated in this test.  Five micro-
liters of blood was taken from the ear lobe and put in 
a tube containing reagents for the G6PD test,  which 
Hirono et al.  described [15].  Finally,  we were intro-
duced to 2 studentsʼ families by the Suizhou Center for 
Disease Control and Prevention.  Members of the 2 
families had been diagnosed with G6PD deﬁciency and 
had previously had episodes of hemolysis (Fig.  1B 
and 1C).
　 G6PD test. Fujiiʼs method was used at 
Shenyang Infectious Disease Hospital and Shengjing 
Hospital [14],  and Hironoʼs method was used at the 
junior high school in Suizhou [15].  A 10µl blood 
sample was taken from each D6PD-deﬁcient individual 
and kept on a ﬁlter sheet for analysis of the G6PD 
gene.
　 Analysis of the G6PD gene. The ﬁlter 
papers containing blood samples were dried,  sent to 
Jichi Medical University,  and kept at －20℃.  DNA 
was eluted from the ﬁlter paper by heating at 80℃ 
for 10min in DNA extraction buﬀer.  DNA extraction 
and puriﬁcation were conducted using a DNA puriﬁca-
tion kit according to the manufacturerʼs instruction 
(Amersham Pharmacia Biotech,  Buckinghamshire,  
UK).  Since genomic G6PD consists of 13 exons,  we 
prepared primers for these exons [11],  ampliﬁed each 
exon by PCR,  and read the DNA sequence (ABI 
PRISM 310; Applied Biosystems,  Foster City,  CA,  
USA).  Both strands of each exon were sequenced.  To 
indicate the mutation point,  the nucleotide number of 
the cDNA sequence was used.
Results
　 We read all the exons encoding the G6PD gene of 
the ﬁrst patient and found a replacement of G to A at 
nucleotide 1339 in exon 11 (Fig.  2A).  As a result,  
the amino acid was expected to change from Gly to Arg 
at position 447 in the molecule.  The sequencing 
results also conﬁrmed that his mother was a heterozy-
gote of G6PD Santiago de Cuba (Fig.  2B) and his 
grandfather was a hemizygote of the same variant.
　 All blood samples collected from the 414 males and 
105 females at the Shenyang Infectious Disease 
Hospital in Liaoning Province showed normal G6PD 
activity.  The rate of G6PD deﬁciency was thus 0ｵ 
(0/414).
　 In Hubei Province in Central China,  we found 2 
males with G6PD deﬁciency among 50 students 
(7.4ｵ; 2 in 27 males).  As described above,  we also 
collected blood samples from 2 families with G6PD 
deﬁciency and analyzed their G6PD genes.  After 
providing the informed consent,  5 individuals from the 
2 families participated.  We found that all of these 
individuals had the G6PD Kaiping (1388G＞T) vari-
ant,  which is one of the most frequent types of G6PD 
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G6PD Santiago de Cuba
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G6PD Kaiping
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G6PD Kaiping
Fig. 1　 Family trees of G6PD deﬁciency.  ■,  hemizygote of G6PD deﬁciency; ,  heterozygote of G6PD deﬁciency; □ and ○,  full 
activity of G6PD; NT,  not tested.  A,  Family 1 was found in Liaoning Province in northeastern China.  B and C,  Families 2 & 3 were from 
Hubei Province in central China.
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variant in the Chinese population.
Discussion
　 Mutation 1339 G＞A was ﬁrst discovered in a 
Cuban boy,  who showed heavy chronic anemia,  and 
was therefore designated G6PD Santiago de Cuba 
[30].  Because the G6PD activity of this variant is 
very low,  patients with this mutation show chronic 
hemolysis and anemia.  Thus this variant is catego-
rized as class I.  Since the amino-acid substitution 
occurs at site 447,  which is close to the dimer inter-
face site [3],  the variant molecule might not be 
formed properly,  causing the enzyme activity to 
decline.
　 In the literature,  28 types of G6PD variant have 
been reported in the Chinese popula-
tion [19-29],  and all are categorized 
as class II or class III,  because they 
do not show chronic hemolytic anemia.  
In such patients,  accidental hemolysis 
occurs only when they ingest certain 
oxidative medicines or foods.  The 
present case and his family members 
with the G6PD Santiago de Cuba 
variant are thus the ﬁrst reported 
cases of class I G6PD deﬁciency in a 
Chinese population.
　 In addition to Cuba and China,  the 
G6PD Santiago de Cuba variant has 
also been reported in Japan [31].  
The patient lived in Iwate Prefecture 
in northern Japan,  and also suﬀered 
form chronic hemolysis and anemia.  
This is the only known case of G6PD 
San tiago de Cuba in the Japanese 
population.  Fiorelli et al.  reported 
that G6PD variants causing chronic 
hemolytic anemia are all sporadic,  and 
almost all arise from independent 
mutations [32].  Moreover,  because 
this variant,  G6PD Santiago de Cuba,  
has been reported in Cuba,  Japan and 
China,  and the number of cases is 
very few,  it is not likely to spread by 
genetic drift.  This suggests that its 
origin is unlikely to be a common 
ancestor and that it is probably a new 
mutation that has arisen independently.
　 Among the blood samples from 414 males and 105 
females collected in Liaoning Province in northeast-
ern China,  there were no cases of G6PD deﬁciency.  
This result suggests that the frequency of G6PD 
deﬁciency is very low in this area.  Similar results 
have been reported by Jiang et al.,  who found that the 
prevalence of G6PD deﬁciency was 0ｵ (0/1,000) in 
Shandong Province in northern China [21].  Luzzatto 
et al.  reported that the frequency of G6PD deﬁciency 
was high in malaria-endemic areas [33].  Individuals 
with G6PD deﬁciency are relatively resistant to falci-
parum malaria,  and thus there is natural selection for 
G6PD-deﬁcient people in areas with malignant malaria 
[34].  As a result,  the frequency of G6PD deﬁciency 
is higher in malaria-endemic areas than in areas where 
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1339G→A
GGG→AGG
Gly→Arg
B
1339G→G/A
GGG→GAGG
Gly→GlyArg
C
1339G
GGG
Gly
Fig. 2　A,  Part of the DNA sequence in exon 11 from a hemizygous boy with G6PD 
Santiago de Cuba; B,  Part of the DNA sequence in exon 11 from a heterozygous 
mother with G6PD Santiago de Cuba; C,  Part of the DNA sequence in exon 11 from 
the boyʼs father with normal G6PD.  Arrows show 1339A,  1339G/A,  and 1339G.
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falciparum malaria has not existed.  In northern areas 
of China,  no falciparum malaria has existed histori-
cally.  This is likely the reason that we found no 
G6PD-deﬁcient cases but sporadic individual in this 
area.
　 Falciparum malaria was endemic to Hubei 
Province in the 1950s to 1970s [35],  which is prob-
ably why the frequency of G6PD deﬁciency was high 
(7.4ｵ) in our very small sampling of this area.  
Although we could not collect more samples from this 
area,  this rate was similar to that from the southern 
part of China.  Studies of G6PD deﬁciency in China 
have been done mainly in the southern part of the 
country.  A high frequency of G6PD deﬁciency (5.2ｵ) 
has been reported in Yunnan Province,  the Guangxi 
Zhuang Autonomous Region,  Guandong Province and 
Fujian Province [21].  Our results suggested that the 
distribution of G6PD deﬁciency in the northern 
regions of China was diﬀerent from that in the central 
and southern areas.  Based only on our ﬁndings,  we 
might speculate that the frequency of G6PD deﬁciency 
and falciparum malaria are positively correlated in 
China.
　 In the Chinese population,  the most common vari-
ants of G6PD are G6PD Kaiping (1388G＞A),  G6PD 
Canton (1376G＞T),  G6PD Gaohe (95G＞A),  G6PD 
Quing Yuan (392C＞T) and G6PD Chinese-5 (1024C
＞T) [36].  These variants are frequently detected in 
Malaysia [37],  Indonesia [10] and Vietnam [11],  
suggesting that they spread from China to these coun-
tries.  Historically,  Chinese people have migrated and 
settled in many countries and geographical regions.  
When G6PD variants in mainland China are compared 
with those in other areas,  we can detect gene ﬂows 
between Chinese and other ethnicities.  For instance,  
G6PD Mediterranean (563C＞T),  which is common in 
Mediterranean countries,  is detected in the Chinese 
population living in Singapore [27],  but this variant 
is never seen on the mainland of China.  We previously 
found G6PD Chatham in a Chinese individual living in 
Surabaya,  Indonesia [5].  This variant has not been 
reported in mainland China,  but is common in 
Indonesia [10] and Iran [38].
　 In conclusion,  a patient with G6PD deﬁciency was 
found in northeastern China.  This patient and his 
family members had a mutation of G6PD Santiago de 
Cuba,  which was classiﬁed as class I according to its 
very low enzyme activity.  This is the ﬁrst reported 
case of a class I G6PD deﬁciency in the Chinese 
population.  In addition,  our screening results suggest 
that the diﬀerence in the distribution of G6PD deﬁ-
ciency in China may be related to the endemicity of 
falciparum malaria.
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